García-Flores EP, Herrera-Maldonado N, Hinojosa-Trejo MA, Vergara-Vázquez M, Halley-Castillo ME

Language: Spanish
References: 10
Page: 57-65
PDF size: 665.20 Kb.

ABSTRACT

Inborn errors of metabolism represent an emerging public health problem that requires timely strategies and ongoing efforts. Currently, the newborn screening is the only method for early detection of this type of diseases, since it allows to identify affected newborns before irreversible damage appears. In the last 6 years, the screening panel at the Ministry of Health in México has increased from 1 to 6 diseases. The financing of the program has been fundamental for the development of the newborn screening program since it has guaranteed it as an integral process, and gradually has increased the assigned resources to this public policy. The hiring of specialized and integral services has allowed a substantial improvement on the results of the newborn screening program, streamlined the delivery of results, guaranteed access to confirmatory tests of 100% of suspected cases in a shorter time, all of this achieved an impact in the reduction of the time of the treatment beginning and therefore in the damage limitation and disability prevention

REFERENCES

1. Guthrie R, Ada S. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963; 32:338-43.

2. De Jesús VR. The role of technology in the neonatal screening laboratory. J Inborn Errors Metab Screen. 2016; 4: doi: 10.1177/2326409816661360.

3. Diario Oficial de la Federación. Decreto por el que se reforma el artículo 61 de la Ley General de Salud. 25 de enero de 2013.

4. Vela-Amieva M, Belmont-Martínez L, Ibarra-González I, Fernández-Lainez C. Variabilidad interinstitucional del tamiz neonatal en México. Bol Med Hosp Infant Mex; 2009; 66(5):431-9.

5. Diario Oficial de la Federación. Acuerdo por el que se emiten las Reglas de Operación del Programa Seguro Médico Siglo XXI, para el ejercicio fiscal 2018. 30 de diciembre de 2017.

6. Catálogo Universal de Servicios de Salud. Comisión Nacional de Protección Social en Salud.2018.

7. Velázquez A, Loera-Luna A, Aguirre BE, Gamboa S, Vargas H, Robles C. Tamiz neonatal para hipotiroidismo congénito y fenilcetonuria. Salud Pública de México. 1994; 36(3): 249-56.

8. Norma Oficial Mexicana NOM-007-SSA2-2016, Para la atención de la mujer durante el embarazo, parto y puerperio, y de la persona recién nacida.

9. Norma Oficial Mexicana NOM-034-SSA2-2013, Para la prevención y control de los defectos al nacimiento.

10. Lineamiento Técnico: Tamiz neonatal: Detección, diagnóstico, tratamiento y seguimiento de los errores innatos del metabolismo. CNEGSR, 2010.